{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:12:26Z","timestamp":1778155946129,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001698","name":"Israel Cancer Research Fund","doi-asserted-by":"publisher","award":["AG-18-204"],"award-info":[{"award-number":["AG-18-204"]}],"id":[{"id":"10.13039\/100001698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019355","name":"Tel Aviv University Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019355","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Biotechnology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.nbt.2025.03.002","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T12:33:09Z","timestamp":1741609989000},"page":"105-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["OncoFlow: A multiplexed microfluidic platform for personalized drug sensitivity assessment"],"prefix":"10.1016","volume":"87","author":[{"given":"Matan","family":"Krasner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efrat","family":"Barbiro-Michaely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike Bening","family":"Abu-Shach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Onn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limor","family":"Broday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0532-2928","authenticated-orcid":false,"given":"Doron","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbt.2025.03.002_bib1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3390\/cancers13020242","article-title":"Personalized medicine: recent progress in cancer therapy","volume":"13","author":"Hoeben","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.nbt.2025.03.002_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nrd3181","article-title":"Personalized medicine in oncology: the future is now","volume":"9","author":"Schilsky","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nbt.2025.03.002_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2019.00049","article-title":"Advancing personalized medicine through the application of whole exome sequencing and big data analytics","volume":"10","author":"Suwinski","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.nbt.2025.03.002_bib4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12916-018-1122-7","article-title":"From hype to reality: data science enabling personalized medicine","volume":"16","author":"Fr\u00f6hlich","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.nbt.2025.03.002_bib5","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa060467","article-title":"A genomic strategy to refine prognosis in early-stage non\u2013small-cell lung cancer","volume":"355","author":"Potti","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nbt.2025.03.002_bib6","first-page":"1","article-title":"Personalized medicine and cancer","volume":"2","author":"Verma","year":"2010","journal-title":"J Pers Med J Pers Med"},{"key":"10.1016\/j.nbt.2025.03.002_bib7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S1367-5931(02)00340-X","article-title":"The path to personalized medicine","volume":"6","author":"Meyer","year":"2002","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.nbt.2025.03.002_bib8","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of larotrectinib in TRK fusion\u2013positive cancers in adults and children","volume":"378","author":"Drilon","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nbt.2025.03.002_bib9","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nbt.2025.03.002_bib10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/bjc.2017.171","article-title":"Tumour heterogeneity poses a significant challenge to cancer biomarker research","volume":"117","author":"Cyll","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nbt.2025.03.002_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.nbt.2025.03.002_bib12","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJMe1200656","article-title":"Tumor heterogeneity and personalized medicine","volume":"366","author":"Longo","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nbt.2025.03.002_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12885-015-1101-8","article-title":"Prediction of resistance to chemotherapy in ovarian cancer: a systematic review","volume":"15","author":"Lloyd","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.nbt.2025.03.002_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.tranon.2014.10.006","article-title":"Personalized in vitro cancer modeling\u2014fantasy or reality?","volume":"7","author":"Bartlett","year":"2014","journal-title":"Transl Oncol"},{"key":"10.1016\/j.nbt.2025.03.002_bib15","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1158\/1535-7163.MCT-11-0233","article-title":"A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer","volume":"10","author":"Hidalgo","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.nbt.2025.03.002_bib16","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1200\/JCO.2004.04.077","article-title":"Chemotherapy sensitivity and resistance assays: a systematic review","volume":"22","author":"Samson","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nbt.2025.03.002_bib17","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1200\/JCO.2011.36.0354","article-title":"American society of clinical oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays","volume":"29","author":"Burstein","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nbt.2025.03.002_bib18","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s41416-020-01033-x","article-title":"pre-clinical animal models are poor predictors of human toxicities in phase 1 oncology clinical trials","volume":"123","author":"Atkins","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nbt.2025.03.002_bib19","first-page":"114","article-title":"Lost in translation: animal models and clinical trials in cancer treatment","volume":"6","author":"Mak","year":"2014","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.nbt.2025.03.002_bib20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s43586-022-00174-y","article-title":"Organoids","volume":"2","author":"Zhao","year":"2022","journal-title":"Nat Rev Methods Prim"},{"key":"10.1016\/j.nbt.2025.03.002_bib21","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3390\/cells12060930","article-title":"Revolutionizing disease modeling: the emergence of organoids in cellular systems","volume":"12","author":"Silva-Pedrosa","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.nbt.2025.03.002_bib22","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nbt.2025.03.002_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41571-023-00745-2","article-title":"Functional precision oncology using patient-derived assays: bridging genotype and phenotype","volume":"20","author":"van Renterghem","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.nbt.2025.03.002_bib24","doi-asserted-by":"crossref","first-page":"9538","DOI":"10.7150\/thno.55954","article-title":"Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept","volume":"11","author":"Morand du Puch","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.nbt.2025.03.002_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/diagnostics8020039","article-title":"Developments in point-of-care diagnostic technology for cancer detection","volume":"8","author":"Hayes","year":"2018","journal-title":"Diagnostics"},{"key":"10.1016\/j.nbt.2025.03.002_bib26","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/nbt871","article-title":"Integrated nanoliter systems","volume":"21","author":"Hong","year":"2003","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nbt.2025.03.002_bib27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature05058","article-title":"The origins and the future of microfluidics","volume":"442","author":"Whitesides","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.nbt.2025.03.002_bib28","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s00216-010-3718-4","article-title":"based microfluidic devices for analysis of clinically relevant analytes present in urine and saliva","volume":"397","author":"Klasner","year":"2010","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.nbt.2025.03.002_bib29","doi-asserted-by":"crossref","DOI":"10.3791\/3849","article-title":"High-throughput Protein Expression Generator Using a Microfluidic Platform","author":"Glick","year":"2012","journal-title":"J Vis Exp"},{"key":"10.1016\/j.nbt.2025.03.002_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C","article-title":"Fabrication of microfluidic systems in poly (dimethylsiloxane)","volume":"21","author":"McDonald","year":"2000","journal-title":"ELECTROPHORESIS: Int J"},{"key":"10.1016\/j.nbt.2025.03.002_bib31","first-page":"113","article-title":"Monolithic microfabricated valves and pumps by multilayer soft lithography","volume":"288","author":"Unger","year":"2000","journal-title":"Science (1979)"},{"key":"10.1016\/j.nbt.2025.03.002_bib32","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1039\/C6LC01534D","article-title":"Control and automation of multilayered integrated microfluidic device fabrication","volume":"17","author":"Kipper","year":"2017","journal-title":"Lab Chip"},{"key":"10.1016\/j.nbt.2025.03.002_bib33","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1039\/C5IB00071H","article-title":"MicroC3: an ex vivo microfluidic cis-coculture assay to test chemosensitivity and resistance of patient multiple myeloma cells","volume":"7","author":"Pak","year":"2015","journal-title":"Integr Biol"},{"key":"10.1016\/j.nbt.2025.03.002_bib34","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1038\/s41598-018-21075-9","article-title":"A microvascularized tumor-mimetic platform for assessing anti-cancer drug efficacy","volume":"8","author":"Pradhan","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.nbt.2025.03.002_bib35","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1039\/D2AN00689H","article-title":"A cascade Fermat spiral microfluidic mixer chip for accurate detection and logic discrimination of cancer cells","volume":"147","author":"Zeng","year":"2022","journal-title":"Analyst"},{"key":"10.1016\/j.nbt.2025.03.002_bib36","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1039\/D2AN01344D","article-title":"Multiplexed microfluidic chip for cell co-culture","volume":"147","author":"Watson","year":"2022","journal-title":"Analyst"},{"key":"10.1016\/j.nbt.2025.03.002_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/srep41541","article-title":"Droplet-based microtumor model to assess cell-ECM interactions and drug resistance of gastric cancer cells","volume":"7","author":"Jang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.nbt.2025.03.002_bib38","unstructured":"Desyatnik, I. et al. An Integrated Microfluidics Approach for Personalized Cancer Drug Sensitivity and Resistance Assay. Adv Biosyst 1900001."},{"key":"10.1016\/j.nbt.2025.03.002_bib39","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.3390\/cells12151921","article-title":"Propofol Inhibits Glioma Stem Cell Growth and Migration and Their Interaction with Microglia via BDNF-AS and Extracellular Vesicles","volume":"12","author":"Nizar","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.nbt.2025.03.002_bib40","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1124\/jpet.105.084145","article-title":"Role of Tyrosine Kinase Inhibitors in Cancer Therapy","volume":"315","author":"Arora","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nbt.2025.03.002_bib41","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1021\/jm2007613","article-title":"Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)","volume":"54","author":"Cui","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.nbt.2025.03.002_bib42","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1158\/1535-7163.MCT-07-0365","article-title":"Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma","volume":"6","author":"Christensen","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.nbt.2025.03.002_bib43","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1158\/0008-5472.CAN-06-4443","article-title":"An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms","volume":"67","author":"Zou","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.nbt.2025.03.002_bib44","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ccr.2011.04.004","article-title":"CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper Mutant","volume":"19","author":"Sakamoto","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.nbt.2025.03.002_bib45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3390\/cancers9090118","article-title":"EML4-ALK Variants: Biological and Molecular Properties, and the Implications for Patients","volume":"9","author":"Sabir","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.nbt.2025.03.002_bib46","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1634\/theoncologist.2009-0092","article-title":"Approval Summary: Pemetrexed in the Initial Treatment of Advanced\/Metastatic Non-Small Cell Lung Cancer","volume":"14","author":"Cohen","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.nbt.2025.03.002_bib47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0093-7754(03)00283-5","article-title":"Pemetrexed (Alimta, MTA, multitargeted antifolate, LY231514) for malignant pleural mesothelioma","volume":"30","author":"Manegold","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1016\/j.nbt.2025.03.002_bib48","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.3390\/diagnostics13193075","article-title":"PTOLEMI: Personalized Cancer Treatment through Machine Learning-Enabled Image Analysis of Microfluidic Assays","volume":"13","author":"Moerdler","year":"2023","journal-title":"Diagnostics"}],"container-title":["New Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871678425000275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871678425000275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:40:59Z","timestamp":1778154059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871678425000275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":48,"alternative-id":["S1871678425000275"],"URL":"https:\/\/doi.org\/10.1016\/j.nbt.2025.03.002","relation":{},"ISSN":["1871-6784"],"issn-type":[{"value":"1871-6784","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OncoFlow: A multiplexed microfluidic platform for personalized drug sensitivity assessment","name":"articletitle","label":"Article Title"},{"value":"New Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbt.2025.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}